SKW Schwarz advises on sale of Omicron NanoTechnology to Oxford Instruments
SKW Schwarz has advised the shareholders of German based Omicron NanoTechnology GmbH on the sale of the company and its international subsidiaries to the high technology tools and systems provider Oxford Instruments plc. The transaction volume amounted to 32,4 million Euro.
Omicron is a globally operating company that designs and produces advanced microscopes and chemical analysis instruments for nanotechnology research. Apart from Germany, Omicron is active in the UK, USA, Japan and France. In 2010, the company generated a revenue of 37,9 million Euro.
Oxford Instruments looks back on 50 years of experience in the design, supply and support of high-technology tools and systems with a focus on research and industrial applications. The company is listed on the London Stock Exchange, and has over 1,500 staff worldwide.
A team SKW Schwarz lawyers from the Frankfurt and the Munich office advised on the transaction together with lawyers of Morris, Nichols, Arsht & Tunnell LLP, a US partner law firm and member of the TerraLex network.
Advisers to Omicron NanoTechnology GmbH
SKW Schwarz Rechtsanwälte, Frankfurt/Munich: Matthias Götz (partner, Frankfurt, M&A, lead), Dr. Andreas Müller-Driver (partner, Munich, M&A), Marc Pussar (associate, Frankfurt, M&A), Michael Wahl (partner, Frankfurt, employment)
Morris, Nichols, Arsht & Tunnell LLP, Delaware: David Hamilton (partner), R. Jason Russell (associate)
Adviser to Oxford Instruments
Ashurst LLP